Hostname: page-component-76fb5796d-vfjqv Total loading time: 0 Render date: 2024-04-26T14:18:42.724Z Has data issue: false hasContentIssue false
  • English
  • Français

Comparative Cost of Selective Screening To Prevent Transmission of Methicillin-Resistant Staphylococcus aureus (MRSA), Compared With the Attributable Costs of MRSA Infection

Published online by Cambridge University Press:  21 June 2016

Laura Gavaldà ,
Cristina Masuet ,
Juan Beltran ,
Maria Garcia ,
Delia Garcia ,
Josep M. Sirvent  and
Josep M. Ramon
Laura Gavaldà*
Affiliation:
Hospital de Girona Dr. Josep Trueta, Girona, Spain Hospital Universitari de Bellvitge, l'Hospitalet de Llobregat, Barcelona, Spain
Cristina Masuet
Affiliation:
Hospital de Girona Dr. Josep Trueta, Girona, Spain Hospital Universitari de Bellvitge, l'Hospitalet de Llobregat, Barcelona, Spain
Juan Beltran
Affiliation:
Hospital de Girona Dr. Josep Trueta, Girona, Spain Hospital Universitari de Bellvitge, l'Hospitalet de Llobregat, Barcelona, Spain
Maria Garcia
Affiliation:
Hospital de Girona Dr. Josep Trueta, Girona, Spain
Delia Garcia
Affiliation:
Hospital de Girona Dr. Josep Trueta, Girona, Spain
Josep M. Sirvent
Affiliation:
Hospital de Girona Dr. Josep Trueta, Girona, Spain
Josep M. Ramon
Affiliation:
Hospital de Girona Dr. Josep Trueta, Girona, Spain Hospital Universitari de Bellvitge, l'Hospitalet de Llobregat, Barcelona, Spain
*
Department of Preventive Medicine, Hospital Universitari de Bellvitge, Feixa Llarga, s/n. 08907 L'Hospitalet de Llobregat, Barcelona, Spain (lgavalda@csub.scs.es)
Get access Rights & Permissions [Opens in a new window]

Abstract

The annual cost of a screening program to detect methicillin-resistant Staphylococcus aureus (MRSA) in a teaching hospital in Spain was €10,261. The average cost per MRSA infection was €2,730; therefore, the cost of the program would be covered if it only prevented 4 infections per year (11% of the total number of MRSA infections at our hospital).

Type
Concise Communications
Information
Infection Control & Hospital Epidemiology , Volume 27 , Issue 11 , November 2006 , pp. 1264 - 1266
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2006

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Muto, CA, Jerigan, JA, Ostrowsky, BE, et al. SHEA guidelines for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus . Infect Control Hosp Epidemiol 2003; 24:362–386.Google Scholar
2. Report of a combined working party of the British Society for Antimicrobial Chemotherapy, the Hospital Infection Society and the Infection Control Nurses Association: revised methicillin-resistant Staphylococcus aureus infection control guidelines for hospitals. 1999. Available at: http://www.his.org.uk/. Accessed May 2004.Google Scholar
3. Garner, JS and the Hospital Infection Control Practices Advisory Committee. Guideline for isolation precautions in hospitals. Infect Control Hosp Epidemiol 1996; 17:53–80.CrossRefGoogle ScholarPubMed
4. Wakefield, DS, Pfaller, MA, Hammons, GT, Massanari, RM. Use of the Appropriateness Evaluation Protocol for estimating the incremental costs associated with nosocomial infections. Med Care 1987; 25:481–488.Google Scholar
5. Zoutman, D, McDonald, S, Vethanayagan, D. Total and attributable costs of surgical-wound infections at a Canadian tertiary-care centre. Infect Control Hosp Epidemiol 1998; 19:254–259.Google Scholar
6. Vilella, A, Prat, A, Trilla, A, Bayas, JM, Asenjo, MA, Salleras, L. Excess length of stay attributable to nosocomial bacteraemia: usefulness of the Hospitalization Appropriateness Protocol. Med Clin (Bare) 1999; 113:608–610.Google ScholarPubMed
7. Kim, T, Oh, PI, Simor, AW. The economic impact of methicillin-resistant Staphylococcus aureus in Canadian hospitals. Infect Control Hosp Epidemiol 2001; 22:99–104.Google Scholar
8. Karchmer, TB, Durbin, LJ, Simonton, BM, Farr, BM. Cost-effectiveness of active surveillance cultures and contact/droplet precautions for control of methicillin-resistant Staphylococcus aureus . J Hosp Infect 2002; 51:126–132.Google Scholar
9. Lucet, JC, Chevret, S, Durand-Zaleski, I, Chastang, C, Reginer, B. Prevalence and risk factors for carriage of methicillin-resistant Staphylococcus aureus at admission on the intensive care unit. Arch Intern Med 2003; 163:181–188.Google Scholar